This conference focuses on outcomes research in chronic kidney disease and end-stage kidney disease, delivery of care in dialysis units and chronic kidney disease clinics, emerging data on new treatments compared to current standard fo care, review of kidney pathology, and basic science research that may become future therapeutics.
Key Words: Nephrology, Clinical Trials, Research
- Physicians
- Nurse Practitioners
- Physician Assistants
- Trainees, Medical Students
Participants who engage in this educational intervention will be able to:
- Evaluate the mechanisms of acute kidney injury related to conventional chemotherapy agents and chimeric antigen receptor T-cell (CAR-T cell) therapy to inform modality selection in clinical practice
- Assess the risk factors for Acute Kidney Injury (AKI) in patients undergoing anti-cancer treatment in a clinical setting.
- Implement preventive strategies and management protocols for minimizing AKI from anti-cancer treatments in a clinical setting
- Assess safety and clinical outcomes of End Stage Kidney Disease for patients receiving CAR T-cell therapy.
Marco Bonilla, MD
Assistant Professor of Medicine
University of Chicago
Christina Mariyam Joy
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.

Facebook
X
LinkedIn
Forward